News
NMTC
3.340
+4.38%
0.140
Weekly Report: what happened at NMTC last week (0615-0619)?
Weekly Report · 4d ago
Weekly Report: what happened at NMTC last week (0608-0612)?
Weekly Report · 06/15 09:38
NeuroOne Expands At-The-Market Equity Offering Capacity
TipRanks · 06/12 23:36
NEUROONE MEDICAL TECHNOLOGIES - FILES UPDATED PROSPECTUS SUPPLEMENT FOR UP TO $13.4 MLN ATM OFFERING - SEC FILING
Reuters · 06/12 20:46
NeuroOne Medical files prospectus for up to $13.4 million at-the-market stock offering
PUBT · 06/12 20:46
NeuroOne Medical restates Q2 product revenue to USD 1.86 million after ASC 606 error
PUBT · 06/12 20:33
Weekly Report: what happened at NMTC last week (0601-0605)?
Weekly Report · 06/08 09:36
Most and least shorted healthcare stocks with market cap up to $2B at the end of May
Seeking Alpha · 06/03 13:45
Weekly Report: what happened at NMTC last week (0525-0529)?
Weekly Report · 06/01 09:38
Weekly Report: what happened at NMTC last week (0518-0522)?
Weekly Report · 05/25 09:40
NeuroOne Restates Quarterly Results After Revenue Recognition Error
TipRanks · 05/22 22:37
NeuroOne Medical Technologies To Restate Q1 2026 Financial Statements; Restatement Corrects $0.5M Revenue Overstatement For Q1 2026; Net Loss Understated By $0.3M For Q1 2026; Restatement Does Not Affect Fy2026 Product Revenue Guidance Or Cash Position
Benzinga · 05/22 21:17
NEUROONE MEDICAL TECHNOLOGIES CORP - NET LOSS UNDERSTATED BY $0.3 MLN FOR Q1 2026 - SEC FILING
Reuters · 05/22 21:13
NEUROONE MEDICAL TECHNOLOGIES CORP - RESTATEMENT CORRECTS $0.5 MLN REVENUE OVERSTATEMENT FOR Q1 2026 - SEC FILING
Reuters · 05/22 21:13
NEUROONE MEDICAL TECHNOLOGIES CORP - RESTATEMENT DOES NOT AFFECT FY2026 PRODUCT REVENUE GUIDANCE OR CASH POSITION - SEC FILING
Reuters · 05/22 21:13
NeuroOne restates March-quarter results after $0.5 million revenue overstatement
PUBT · 05/22 20:32
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 05/19 21:06
Weekly Report: what happened at NMTC last week (0511-0515)?
Weekly Report · 05/18 09:40
NeuroOne Medical Tech Is Maintained at Buy by Ladenburg Thalmann
Dow Jones · 05/13 20:47
NeuroOne Medical Tech Price Target Raised to $8.00/Share From $1.60 by Ladenburg Thalmann
Dow Jones · 05/13 20:47
More
Webull provides a variety of real-time NMTC stock news. You can receive the latest news about Neuroone Med Technologies Corp through multiple platforms. This information may help you make smarter investment decisions.
About NMTC
NeuroOne Medical Technologies Corporation is a medical technology company. It is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. It may also pursue applications for other areas such as depression, mood disorders, incontinence and artificial intelligence. Its products include Evo cortical electrode technology for recording, monitoring, and stimulating brain tissue for up to 30 days; Evo sEEG electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain, and OneRF ablation system for creation of radiofrequency lesions in nervous tissue for functional neurosurgical procedures.